| 1 | [ravulizumab] (D11054) | 1件: Ravulizumab Ravulizumab | 1件: Ravulizumab
Ravulizumab
(D11054) 💬
| 1件: C5 C5 💬
| 11件: Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | 1件: 62 62 💬
|
| 2 | Combination Product: Ravulizumab OBDS (D11054) | 1件: Ravulizumab Ravulizumab | 1件: Ravulizumab
Ravulizumab
(D11054) 💬
| 1件: C5 C5 💬
| 11件: Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | 1件: 62 62 💬
|
| 3 | Other: early use of Ravulizumab (D11054) | 1件: Ravulizumab Ravulizumab | 1件: Ravulizumab
Ravulizumab
(D11054) 💬
| 1件: C5 C5 💬
| 11件: Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | 1件: 11 11 💬
|
| 4 | Ravulizumab (D11054) | 1件: Ravulizumab Ravulizumab | 1件: Ravulizumab
Ravulizumab
(D11054) 💬
| 1件: C5 C5 💬
| 11件: Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | 8件: 2 2, 11, 13, 50, 62, 66, 109, 224 💬
|
| 5 | ULTOMIRIS ™ (ravulizumab-cwvz) (D11054) | 1件: Ravulizumab Ravulizumab | 1件: Ravulizumab
Ravulizumab
(D11054) 💬
| 1件: C5 C5 💬
| 11件: Alcoholic liver disease Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬 | 1件: 62 62 💬
|